Drug Development - Targeting HER2 beyond Trastuzumab

被引：0
|
作者：
Spector, N. L. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PL2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL2-1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance
    Pedersen, Mikkel W.
    Jacobsen, Helle J.
    Koefoed, Klaus
    Dahlman, Anna
    Kjaer, Ida
    Poulsen, Thomas T.
    Meijer, Per-Johan
    Nielsen, Lars S.
    Horak, Ivan D.
    Lantto, Johan
    Kragh, Michael
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 669 - 680
  • [22] Beyond EGFR inhibitors in advanced colorectal cancer: Targeting BRAF and HER2
    Dao, Vinh
    Heestand, Gregory
    CURRENT PROBLEMS IN CANCER, 2023, 47 (04)
  • [23] Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium
    Hingorani, Pooja
    Zhang, Wendong
    Zhang, Zhongting
    Xu, Zhaohui
    Wang, Wei -Lien
    Roth, Michael E.
    Wang, Yifei
    Gill, Jonathan B.
    Harrison, Douglas J.
    Teicher, Beverly A.
    Erickson, Stephen W.
    Gatto, Gregory
    Kolb, Edward A.
    Smith, Malcolm A.
    Kurmasheva, Raushan T.
    Houghton, Peter J.
    Gorlick, Richard
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (08) : 1318 - 1325
  • [24] HER2 testing and correlation with efficacy of trastuzumab therapy
    Fornier, M
    Risio, M
    Van Poznak, C
    Seidman, A
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 1340 - +
  • [25] HER2 therapy: Molecular mechanisms of trastuzumab resistance
    Rita Nahta
    Francisco J Esteva
    Breast Cancer Research, 8
  • [26] Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab
    Franco, Andreia Fabiana do Vale
    Malinverni, Andrea Cristina Moraes
    Waitzberg, Angela Flavia Logullo
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 252
  • [27] HER2 therapy - Molecular mechanisms of trastuzumab resistance
    Nahta, Rita
    Esteva, Francisco J.
    BREAST CANCER RESEARCH, 2006, 8 (06):
  • [28] Involvement of microRNAs in HER2 signaling and trastuzumab treatment
    Mao, Ling
    Sun, Ai-jun
    Wu, Jian-zhong
    Tang, Jin-hai
    TUMOR BIOLOGY, 2016, 37 (12) : 15437 - 15446
  • [29] Trastuzumab administration associated with change in HER2 status
    Dawood, Shaheenah
    Resetkova, Erika
    Gonzalez-Angulo, Ana M.
    CLINICAL BREAST CANCER, 2008, 8 (04) : 366 - 369
  • [30] HER2 overexpression and cancer targeting
    Wang, SC
    Hung, MC
    SEMINARS IN ONCOLOGY, 2001, 28 (05) : 115 - 124
12345